16:08 EDT NeuroBo Pharmaceuticals files $150M mixed securities shelf
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NRBO:
- NeuroBo Pharmaceuticals Reports Year End 2023 Financial Results and Provides Corporate Update
- NeuroBo Pharmaceuticals cleared to continue Phase 2a trial of DA-1241
- NeuroBo Pharmaceuticals names Marshall Woodworth as CFO
- NeuroBo Pharmaceuticals Announces Key Leadership Appointment
- NeuroBo Pharmaceuticals receives first site IRB approval for obesity trial